Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with ...

www.trevitherapeutics.com (PRNewsfoto/Trevi Therapeutics, Inc.) "I am happy to share these robust positive results from our Phase 2a RIVER trial in refractory chronic cough which has been a ...

Investing.com -- Shares of Arvinas, Inc. (NASDAQ:ARVN) plummeted 41% today following the announcement of positive topline results from its Phase 3 VERITAC-2 clinical trial. Despite meeting its ...

(Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus fulvestrant ...

CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy bodies (DLB). A new batch of neflamapimod capsules led to increased plasma ...

Agomab Therapeutics NV (Agomab) has announced positive interim results from 44 patients completing treatment in the ongoing STENOVA phase 2a clinical trial for AGMB-129. AGMB-129 is an oral ...

Purple Biotech reports positive trial results for CM24 and NT219, advancing toward biomarker-driven studies and expanding its oncology pipeline. Purple Biotech Ltd. announced positive results from ...